Clinical trial · Interventional
The Effectiveness and Mechanism Study of Auricular Needling in Treating Cancer Induced Anorexia
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Controlling of cancer induced anorexia is highly demanded by advanced cancer patients. It plays an important role in improving the quality of life among advanced cancer patients. Through a randomized controlled single blinded clinical research, we will observe the differences of appetite, food intake amount, weight and KPS between the auricular needling treating group and control group before and after the treatment. Based on the results of the research, we can prove the clinical effectiveness of auricular needling in treating cancer induced anorexia and possible mechanism of the method.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Anorexia Nervosa | — | UNRESOLVED | — |
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| auricular needling | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Auricular Needling group
- description
- Patients will receive auricular needling for 4 weeks .
- interventionNames
- Other: auricular needling
- type
- NO_INTERVENTION
- label
- control group
- description
- This group will receive no treatment. Subjects will be assessed at baseline and the 2th, 4th and 8th week.
Primary outcomes (2)
- measure
- Simple Appetite Questionnaire
- timeFrame
- 10 weeks
- description
- The Simplified Nutritional Appetite Questionnaire (SNAQ) is used to assess the patient's appetite.Possible scores range from 4（poor appetite) to20（good appetite）.The score lower than 14 predicts a risk of 5% weight loss.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * Histologically confirmed diagnosis of malignant cancer of stage III or IV * Meet the diagnosis criteria of cancer induced anorexia * Karnofsky performance status(KPS) score≥ 60 * Expected survival time≥3 months * Willing to give informed consent * Able to comply with trial protocol Exclusion Criteria: * have blood routine, hepatic and renal disfunction,which is over 2 times of the normal value * obvious eating disorder, intestinal obstruction, poor controlled heart disease and diabetes * who are receiving progesterone, glucocorticoid or other hormone Therapy * those who are participating in other trials. * pregnant women, nursing mother or psychotic patients
References
Publications (0)
Data not yet available